28 July, 2026
Sidra Medicine Administers Qatar’s First ItvismaTM Gene Therapy for Spinal Muscular Atrophy
One-time gene replacement therapy expands access to precision treatment for eligible children, adolescents, and adults living with spinal muscular atrophy Doha, Qatar – 28 July 2026: Sidra Medicine, a member